(Q54234724)

26 May 2018

title

4-Hydroxy-α-tetralone and its derivative as drug resistance reversal agents in multi drug resistant Escherichia coli. (English)

1 reference

26 May 2018

main subject

multiple drug resistance

1 reference

1 reference

Dharmendra K Yadav

3

0 references

Gaurav Raj Dwivedi

object named as

Gaurav R Dwivedi

1

0 references

Feroz Khan

object named as

Feroz Khan

6

0 references

author name string

Harish C Upadhyay

2

1 reference

26 May 2018

Vigyasa Singh

4

1 reference

26 May 2018

Santosh K Srivastava

5

1 reference

26 May 2018

Nandan S Darmwal

7

1 reference

26 May 2018

Mahendra P Darokar

8

1 reference

26 May 2018

publication date

1 April 2014

1 reference

26 May 2018

Chemical Biology and Drug Design

published in

1 reference

26 May 2018

volume

83

1 reference

26 May 2018

issue

4

1 reference

26 May 2018

page(s)

482-492

1 reference

26 May 2018

Multidrug resistance in bacteria

cites work

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12263

Multidrug-resistance efflux pumps - not just for resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12263

Mechanisms of drug efflux and strategies to combat them: challenging the efflux pump of Gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12263

Molecular basis of bacterial outer membrane permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12263

Efflux pumps: their role in antibacterial drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12263

Botanical drugs, synergy, and network pharmacology: forth and back to intelligent mixtures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12263

Bioenhancing and antimycobacterial agents from Ammannia multiflora.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12263

Antimicrobial activity of quinupristin-dalfopristin combined with other antibiotics against vancomycin-resistant enterococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12263

Characterization of fluoroquinolone-resistant mutants of escherichia coli selected in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12263

Evaluation of efflux activity of bacteria by a semi-automated fluorometric system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12263

Cloning, sequencing and functional expression in Escherichia coli of the gene for a P-type Na(+)-ATPase of a facultatively anaerobic alkaliphile, Exiguobacterium aurantiacum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12263

Utilization of membrane vesicle preparations to study drug–ABC transporter interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12263

YojI of Escherichia coli functions as a microcin J25 efflux pump

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12263

Conditions that may affect the results of susceptibility testing of Mycobacterium tuberculosis to pyrazinamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12263

The efflux pump inhibitor reserpine selects multidrug-resistant Streptococcus pneumoniae strains that overexpress the ABC transporters PatA and PatB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12263

Has the era of untreatable infections arrived?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12263

Enhancement by novel anti-methicillin-resistant Staphylococcus aureus compound HT61 of the activity of neomycin, gentamicin, mupirocin and chlorhexidine: in vitro and in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12263

Anti-infective potential of natural products: how to develop a stronger in vitro 'proof-of-concept'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12263

Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5'-methoxyhydnocarpin, a multidrug pump inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12263

Piperine, a phytochemical potentiator of ciprofloxacin against Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12263

Capsaicin, a novel inhibitor of the NorA efflux pump, reduces the intracellular invasion of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12263

Potential role of non-antibiotics (helper compounds) in the treatment of multidrug-resistant Gram-negative infections: mechanisms for their direct and indirect activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12263

Distribution and physiology of ABC-type transporters contributing to multidrug resistance in bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12263

Novel macrolide-specific ABC-type efflux transporter in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12263

Identification of efflux-mediated multi-drug resistance in bacterial clinical isolates by two simple methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12263

Bacterial efflux systems and efflux pumps inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12263

Antibiotic stress, genetic response and altered permeability of E. coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12263

Inducement and reversal of tetracycline resistance in Escherichia coli K-12 and expression of proton gradient-dependent multidrug efflux pump genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12263

Multidrug resistance in Gram-negative bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12263

Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12263

Multiple molecular mechanisms for multidrug resistance transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12263

Antibacterial and Synergy of Clavine Alkaloid Lysergol and its Derivatives Against Nalidixic Acid-ResistantEscherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FCBDD.12263

21 January 2018

Identifiers

DOI

10.1111/CBDD.12263

1 reference

26 May 2018

1 reference

26 May 2018